Prevention of post-contrast kidney injury in patients with cancer.

Q2 Pharmacology, Toxicology and Pharmaceutics

Drugs in Context Pub Date : 2024-03-14 eCollection Date: 2024-01-01 DOI:10.7573/dic.2023-11-2

Emanuele Grassedonio, Lorena Incorvaia, Marco Guarneri, Fabio Guagnini, Massimo Midiri

引用次数: 0

Abstract

Post-contrast acute kidney injury is defined as a nephropathy with an increase in serum creatinine of >0.3 mg/dL (or >26.5 μmol/L) or >1.5-times the baseline within 48-72 h of intravascular administration of a contrast medium. Patients with cancer have an increased risk of post-contrast acute kidney injury not only related to the frequent use of contrast medium for computed tomography scans but also to other factors, including the type of tumour, age, oncological therapies, use of other nephrotoxic agents and dehydration. Preventive strategies were developed and may be applied to different risk profiles. Patients at risk may be detected by recently published risk scores.

查看原文本刊更多论文

预防癌症患者造影后肾损伤。

造影后急性肾损伤是指在血管内注射造影剂后 48-72 小时内，血清肌酐升高大于 0.3 mg/dL（或大于 26.5 μmol/L）或大于基线 1.5 倍的肾病。癌症患者造影后急性肾损伤的风险增加不仅与计算机断层扫描中造影剂的频繁使用有关，还与其他因素有关，包括肿瘤类型、年龄、肿瘤治疗、其他肾毒性药物的使用和脱水。预防策略已经制定，可适用于不同的风险情况。可以通过最近公布的风险评分来检测高危患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Drugs in Context Medicine-Medicine (all)

CiteScore

5.90

自引率

0.00%

发文量

审稿时长

9 weeks

期刊介绍： Covers all phases of original research: laboratory, animal and human/clinical studies, health economics and outcomes research, and postmarketing studies. Original research that shows positive or negative results are welcomed. Invited review articles may cover single-drug reviews, drug class reviews, latest advances in drug therapy, therapeutic-area reviews, place-in-therapy reviews, new pathways and classes of drugs. In addition, systematic reviews and meta-analyses are welcomed and may be published as original research if performed per accepted guidelines. Editorials of key topics and issues in drugs and therapeutics are welcomed. The Editor-in-Chief will also consider manuscripts of interest in areas such as technologies that support diagnosis, assessment and treatment. EQUATOR Network reporting guidelines should be followed for each article type. GPP3 Guidelines should be followed for any industry-sponsored manuscripts. Other Editorial sections may include Editorial, Case Report, Conference Report, Letter-to-the-Editor, Educational Section.